Literature DB >> 17258775

Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.

Kenji Ishihara1, Aki Takahashi, Motoko Kaneko, Hiroki Sugeno, Noriyasu Hirasawa, JangJa Hong, OkPyo Zee, Kazuo Ohuchi.   

Abstract

EoL-1 cells differentiate into eosinophils in the presence of n-butyrate, but the mechanism has remained to be elucidated. Because n-butyrate can inhibit histone deacetylases, we hypothesized that the inhibition of histone deacetylases induces the differentiation of EoL-1 cells into eosinophils. In this study, using n-butyrate and two other histone deacetylase inhibitors, apicidin and trichostatin A, we have analyzed the relationship between the inhibition of histone deacetylases and the differentiation into eosinophils in EoL-1 cells. It was demonstrated that apicidin and n-butyrate induced a continuous acetylation of histones H4 and H3, inhibited the proliferation of EoL-1 cells without attenuating the level of FIP1L1-PDGFRA mRNA, and induced the expression of markers for mature eosinophils such as integrin beta7, CCR1, and CCR3 on EoL-1 cells, while trichostatin A evoked a transient acetylation of histones and induced no differentiation into eosinophils. These findings suggest that the continuous inhibition of histone deacetylases in EoL-1 cells induces the differentiation into mature eosinophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258775     DOI: 10.1016/j.lfs.2006.12.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Cancer cells' epigenetic composition and predisposition to histone deacetylase inhibitor sensitization.

Authors:  Narasimharao Nalabothula; France Carrier
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

2.  Novel association between vasoactive intestinal peptide and CRTH2 receptor in recruiting eosinophils: a possible biochemical mechanism for allergic eosinophilic inflammation of the airways.

Authors:  Amr E El-Shazly; Dominique Y Begon; Gaelle Kustermans; Mohammad Arafa; Estelle Dortu; Monique Henket; Philippe P Lefebvre; Renaud Louis; Philippe Delvenne
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

3.  Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation.

Authors:  Ji-Sook Lee; In Sik Kim
Journal:  Mol Biol Rep       Date:  2009-08-11       Impact factor: 2.316

4.  HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2.

Authors:  Philippos Peidis; Andreas I Papadakis; Kamindla Rajesh; Antonis E Koromilas
Journal:  Aging (Albany NY)       Date:  2010-10       Impact factor: 5.682

5.  ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.

Authors:  Nina Germic; Aref Hosseini; Darko Stojkov; Kevin Oberson; Meike Claus; Charaf Benarafa; Sara Calzavarini; Anne Angelillo-Scherrer; Isabelle C Arnold; Anne Müller; Carsten Riether; Shida Yousefi; Hans-Uwe Simon
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

Review 6.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

7.  CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription.

Authors:  Tae Gi Uhm; Seol Kyung Lee; Byung Soo Kim; Jin Hyun Kang; Choon Sik Park; Tai Youn Rhim; Hun Soo Chang; Do Jin Kim; Il Yup Chung
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

8.  Identification of inflammatory markers in eosinophilic cells of the immune system: fluorescence, Raman and CARS imaging can recognize markers but differently.

Authors:  Aleksandra Borek-Dorosz; Marek Grosicki; Jakub Dybas; Ewelina Matuszyk; Marko Rodewald; Tobias Meyer-Zedler; Michael Schmitt; Juergen Popp; Kamilla Malek; Malgorzata Baranska
Journal:  Cell Mol Life Sci       Date:  2021-12-22       Impact factor: 9.261

9.  Comparative Analysis of Dibutyric cAMP and Butyric Acid on the Differentiation of Human Eosinophilic Leukemia EoL-1 Cells.

Authors:  YunJae Jung
Journal:  Immune Netw       Date:  2015-12-24       Impact factor: 6.303

10.  DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells.

Authors:  Rabindranath Bera; Ming-Chun Chiu; Ying-Jung Huang; Gang Huang; Yun-Shien Lee; Lee-Yung Shih
Journal:  Oncogenesis       Date:  2020-02-03       Impact factor: 6.524

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.